Owing to the heterogeneous nature of lesion types and management, as well as follow-up and potential study bias, the incidence of recurrence of squamous cell carcinoma in the hand varies in this review. The uncertainty in the evidence is reflected by discrepancies in international guidelines. Further research is needed to establish recurrence risk and inform management decisions.
McMillan et al. (Sun,) studied this question.